Core Points - Sana Biotechnology, Inc. will present at the TD Cowen Immunology & Inflammation Summit on November 12, 2025, at 1:30 p.m. ET, featuring a business overview by CEO Steve Harr [1] - The presentation will be available via webcast on the company's Investor Relations page, with a replay accessible for 30 days post-conference [2] - Sana Biotechnology focuses on engineered cells as medicines, aiming to repair genes and replace damaged cells, with operations in Seattle, Cambridge, and South San Francisco [3]